20n
DefunctYC W15San Francisco, US · 2 employees · 1 known investors
20n uses machine learning and computational biology to predict DNA sequences for industrial biotech and pharmaceutical applications. The company serves manufacturing firms developing biologically-based alternatives to traditional chemical production of fuels, materials, therapeutics, and specialty chemicals.
AI & Machine LearningBiotechHealthtechArtificial IntelligenceUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (W15)
SS
Saurabh Srivastavain𝕏Founder/CEOSaurabh Srivastava completed a PhD and postdoctoral research in code synthesis using theorem provers. He served as Head of Code Research at Essential AI, and previously founded two YC-backed companies focused on code synthesis for biological and automation applications. He currently works on code model development at NVIDIA.
CA
Chris AndersonFounder/CSO
Investors · 1
In the news
Frequently asked questions
- What does 20n do?
- 20n uses machine learning and computational biology to predict DNA sequences for industrial biotech and pharmaceutical applications. The company serves manufacturing firms developing biologically-based alternatives to traditional chemical production of fuels, materials, therapeutics, and specialty chemicals.
- Who founded 20n?
- 20n was founded by Saurabh Srivastava, Chris Anderson.
- Who are 20n's investors?
- 20n's investors include Y Combinator.
- Where is 20n headquartered?
- 20n is headquartered in San Francisco, US.